Indo Amines Q1 FY27 Results (NSE: INDOAMIN)
Signal: Growth reaccelerated
The read
The operating trajectory improved sharply, with consolidated revenue accelerating to ₹374.64 Cr, up 30.3% YoY, and EBITDA margin at 14.5% versus 11% in the Q1FY26 prior-results series; however, PAT growth slowed to 6.7% from 45.4% in Q1FY26, while standalone PAT grew 20.1%, making subsidiary drag and earnings conversion the key items to monitor.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹374.64 Cr | 30.3% | N/A |
| EBIT | ₹47.92 Cr | 14.8% | |
| Net profit | ₹30.76 Cr | 6.7% | |
| EPS | ₹4.19 | 6.3% | |
| EBIT margin | 14.5% |
P&L walk
Consolidated revenue accelerated to ₹374.64 Cr, up 30.3% YoY, while EBITDA rose 15.8% to ₹54.24 Cr at a 14.5% margin; EBIT grew 14.8% to ₹47.92 Cr but PAT increased only 6.7% to ₹30.76 Cr.
Segments
No segment results table was disclosed; standalone revenue grew 35.6% YoY to ₹367.31 Cr versus consolidated growth of 30.3% to ₹374.64 Cr, indicating subsidiary-level drag on the group result.
Key positives
- Consolidated revenue rose 30.3% YoY to ₹374.64 Cr, accelerating from 8.7% YoY growth in Q1FY26.
- Standalone EBITDA grew 24.0% YoY to ₹53.25 Cr and standalone EBIT grew 24.1% to ₹47.12 Cr, showing stronger operating momentum at the parent level.
- EBITDA margin was 14.5%, above the 11% OPM recorded in the Q1FY26 prior-results series.
- EPS tracked PAT closely on a consolidated basis, with EPS up 6.3% YoY to ₹4.19 versus PAT growth of 6.7%.
Key concerns
- Consolidated PAT increased only 6.7% YoY to ₹30.76 Cr, trailing revenue growth of 30.3% and EBITDA growth of 15.8%.
- Standalone PAT grew 20.1% YoY to ₹30.61 Cr versus consolidated PAT growth of 6.7%, indicating that subsidiaries diluted group-level earnings momentum.
- Consolidated EBITDA growth of 15.8% lagged standalone EBITDA growth of 24.0%, requiring better disclosure on subsidiary operating performance and profitability.
Research and educational content only. Not investment advice.